title: [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
abstract: Eight male tuberculous patients, between 20 and 60 years of age, were given Isoniazid 5 mg/kg and Ketoconazole 200 mg, first one at a time and then associated. Plasma concentrations were measured 0, 2 and 5 hs after taking the drugs. Isoniazid was measured by spectrophotometry and Ketoconazole by the microbiologic method with Candida albicans as test microorganism. When both drugs were given simultaneously Ketoconazole plasma concentration decreased 75% at 2 hs (p less than 0.025) and 85% at 5 hs (p less than 0.05), whereas that of Isoniazid remained unchanged (Table 1). Mean half-life of Isoniazid was 3.9 +/- 1.4 hs in 7 slow acetylators and 1.1 hs in one fast acetylator when given one at a time and 4.4 +/- 1.5 hs when given simultaneously. A similar study was conducted on 11 tuberculous patients who were given Rifampicin 10 mg/kg and Ketoconazole 200 mg, one at a time and concurrently. Rifampicin was measured by high pressure liquid chromatography. When Rifampicin and Ketoconazole were given concurrently plasma concentration of both drugs was reduced: Ketoconazole decreased 85% at 2 hs (p less than 0.025) and 98% at 5 hs (p less than 0.025) whereas Rifampicin decreased 45% at 2 hs (p less than 0.005) and 40% at 5 hs (p less than 0.005) (Table 2). Mean half-life of Rifampicin was 3.5 +/- 0.8 and 4.2 +/- 1.1 hs, respectively, when it was given alone and concurrently. Studies on chemical interactions between Isoniazid and Ketoconazole and between Rifampicin and Ketoconazole yielded negative results.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: J A
authors.initials: JA
authors.lastname: Pilheu
authors.forename: M R
authors.initials: MR
authors.lastname: Galati
authors.forename: A S
authors.initials: AS
authors.lastname: Yunis
authors.forename: M C
authors.initials: MC
authors.lastname: De Salvo
authors.forename: R
authors.initials: R
authors.lastname: Negroni
authors.forename: J C
authors.initials: JC
authors.lastname: García Fernández
authors.forename: L
authors.initials: L
authors.lastname: Mingolla
authors.forename: M C
authors.initials: MC
authors.lastname: Rubio
authors.forename: M
authors.initials: M
authors.lastname: Masana
authors.forename: C
authors.initials: C
authors.lastname: Acevedo
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000097:blood*; D007654:Ketoconazole / Q000008:administration & dosage / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood*; D014376:Tuberculosis / Q000188:drug therapy / Q000378:metabolism*
chemical_list: D007654:Ketoconazole; D007538:Isoniazid; D012293:Rifampin
vernacular_title: Interacción farmacocinética entre ketoconazol, isoniacida y rifampicina.